0.005 AUD
747.33 K AUD
26.02 M AUD
30.52 M
About STAR COMBO PHARMA LIMITED
Sector
CEO
Su Zhang
Headquarters
Smithfield
Website
Founded
2016
ISIN
AU0000004798
FIGI
BBG00K4LGNJ6
Star Combo Pharma Ltd. engages in the manufacture and distribution of vitamis, dietary supplements, and skincare products. It operates through the segments: Star Combo and Austoyou. The Star Combo engages in developing, manufacturing, marketing and sale of natural health supplements and ski8n care products. The Austoyou segment offers product lines to Chinese health product consumers. The company was founded by Star Zhang in 2004 and is headquartered in Smithfield, Australia.
ASX Star Combo Pharma Star Combo Pharma has just started trading last week. It has a good run up to above $2. I believe this is Wave 1 of Elliot. The price has dropped a bit at writing and if I am not wrong, corrective wave 2 will probably hit between 0.5 to 0.618 in the next few days. If i were to trade, i would look
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of S66 is 0.150 AUD — it hasn't changed in the past 24 hours. Watch STAR COMBO PHARMA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange STAR COMBO PHARMA LIMITED stocks are traded under the ticker S66.
S66 stock hasn't changed in a week, the last month showed zero change in price, over the last year STAR COMBO PHARMA LIMITED has showed a 36.36% increase.
S66 stock is 0.00% volatile and has beta coefficient of 0.16. Track STAR COMBO PHARMA LIMITED stock price on the chart and check out the list of the most volatile stocks — is STAR COMBO PHARMA LIMITED there?
Yes, you can track STAR COMBO PHARMA LIMITED financials in yearly and quarterly reports right on TradingView.
S66 net income for the last half-year is 621.63 K AUD, while the previous report showed 125.70 K AUD of net income which accounts for 394.51% change. Track more STAR COMBO PHARMA LIMITED financial stats to get the full picture.
Yes, S66 dividends are paid annually. The last dividend per share was 0.00 AUD. As of today, Dividend Yield (TTM)% is 2.47%. Tracking STAR COMBO PHARMA LIMITED dividends might help you take more informed decisions.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STAR COMBO PHARMA LIMITED EBITDA is 999.32 K AUD, and current EBITDA margin is 6.80%. See more stats in STAR COMBO PHARMA LIMITED financial statements.
Like other stocks, S66 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STAR COMBO PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STAR COMBO PHARMA LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STAR COMBO PHARMA LIMITED stock shows the neutral signal. See more of STAR COMBO PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.